Serotonin Syndrome

Also known as: Serotonin syndrome (disorder) / Carcinoid syndrome / Malignant Carcinoid Syndrome / Carcinoid syndrome (disorder)

Drug	Drug Name	Drug Description
DB00434	Cyproheptadine	A combined serotonin and histamine antagonist used in the treatment of allergic symptoms, for appetite stimulation, and off-label in the treatment of serotonin syndrome.

Drug	Drug Name	Target	Type
DB00434	Cyproheptadine	5-hydroxytryptamine receptor 2A	target
DB00434	Cyproheptadine	Histamine H1 receptor	target
DB00434	Cyproheptadine	Muscarinic acetylcholine receptor M1	target
DB00434	Cyproheptadine	Muscarinic acetylcholine receptor M2	target
DB00434	Cyproheptadine	Muscarinic acetylcholine receptor M3	target
DB00434	Cyproheptadine	5-hydroxytryptamine receptor 2C	target
DB00434	Cyproheptadine	UDP-glucuronosyltransferase 1-3	enzyme
DB00434	Cyproheptadine	5-hydroxytryptamine receptor 7	target
DB00434	Cyproheptadine	UDP-glucuronosyltransferase 2B10	enzyme
DB00434	Cyproheptadine	UDP-glucuronosyltransferase 1-4	enzyme
DB00434	Cyproheptadine	5-hydroxytryptamine receptor 2B	target
DB00434	Cyproheptadine	Histamine H2 receptor	target
DB00434	Cyproheptadine	Solute carrier family 22 member 1	transporter
DB00434	Cyproheptadine	Serum albumin	carrier

Drug	Drug Name	Phase	Status	Count
DB00434	Cyproheptadine	2	Not Yet Recruiting	1
DB00434	Cyproheptadine	3	Not Yet Recruiting	1
DB01367	Rasagiline	Not Available	Completed	1